Trademark: 97382032
Word
NANOPORTAL
Status
Pending
Status Code
654
Status Date
Thursday, December 14, 2023
Serial Number
97382032
Mark Type
4000
Filing Date
Tuesday, April 26, 2022

Trademark Owner History

Classifications
5 Implantable drug delivery devices injected through a small needle having a drug reservoir filled with pharmaceutical preparations and a nanoporous membrane for improving medication adherence in the treatment of chronic diseases including, for example, metabolic diseases such as diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases such as Alzheimer's, dementia, sociopathy or psychopathy
1 Nanoporous membranes used in drug delivery devices injected through a small needle for controlling the rate of release of the subject therapeutic compound by selecting nano-pores slightly larger than the molecular diameter of the therapeutic compound; nanoporous membranes used for controlling the rate of release of the subject therapeutic compound by selecting nano-pores slightly larger than the molecular diameter of the therapeutic compound that control the amount and rate of drug released from a drug implant injected through a small needle where the drug reservoir dictates the duration of therapy delivered from the drug implant
10 Implantable drug delivery devices injected through a small needle having a drug reservoir and a nanoporous membrane; Nanoporous membranes used in drug delivery devices injected through a small needle for improving medication adherence in the treatment of chronic diseases including, for example, metabolic diseases such as diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases such as Alzheimer's, dementia, sociopathy or psychopathy; miniature long-term drug implants utilizing proprietary implantable drug delivery technology; nanoporous membranes used for improving medication adherence in the treatment of chronic diseases including, for example, metabolic diseases such as diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases such as Alzheimer's, dementia, sociopathy or psychopathy that control the amount and rate of drug released from a drug implant injected through a small needle where the drug reservoir dictates the duration of therapy delivered from the drug implant for treatment of metabolic diseases such as diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases such as Alzheimer's, dementia, sociopathy or psychopathy, and other diseases treated with small drug molecules

Trademark Events
Dec 14, 2023
Report Completed Suspension Check Case Still Suspended
May 30, 2023
Notification Of Letter Of Suspension E-Mailed
May 30, 2023
Letter Of Suspension E-Mailed
May 30, 2023
Suspension Letter Written
May 13, 2023
Teas/Email Correspondence Entered
May 12, 2023
Correspondence Received In Law Office
May 12, 2023
Teas Response To Office Action Received
Feb 15, 2023
Notification Of Non-Final Action E-Mailed
Feb 15, 2023
Non-Final Action E-Mailed
Feb 15, 2023
Non-Final Action Written
Feb 13, 2023
Assigned To Examiner
May 2, 2022
New Application Office Supplied Data Entered
Apr 29, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24